Cost analysis of antifungal drugs available in India: A pharmacoeconomic perspective
Journal Title: Indian Journal of Pharmacy and Pharmacology - Year 2016, Vol 3, Issue 4
Abstract
Introduction: Fungal infections are common and treatment imposes economic burden on the patients. The compliance of the patient may be significantly dependent on the cost of the prescribed medicines, especially in developing countries like India. Therefore, this study was conducted to analyze cost variation of drugs used for fungal infections. Aim and Objectives: To evaluate the cost of different brands of anti-fungal drugs available in India, and to analyze the variations in cost of same dosage of different brands of the same active drug. Material and Methods: Cost of a particular drug that is manufactured by different companies, in the same strength, number and dosage forms was obtained from Current Index of Medical Specialties, July-October 2016 and Drug Today, July-September 2016 and were analysed. Cost range, cost ratio and percentage cost variation were calculated. Correlation between percentage cost variation and number of companies manufacturing the drug was analysed by linear regression and Spearman correlation analysis. p < 0.05 was considered statistically significant. Result: The costs of a total of 8 antifungal drugs available in 18 different formulations were analysed and a substantial variation in cost was found. Fourteen drugs had percentage cost variation more than 100%, fluconazole 150 mg (10214%) had maximum percentage cost variation while griseofulvin 500 mg (42%) had minimum percentage cost variation. There was a linear relationship between no. of manufacturing companies and percentage cost variation and Spearman correlation analysis showed a statistically significant positive correlation between these two variables. Conclusion: The present study shows wide variation in the cost of the different brands of the same antifungal drugs manufactured by different companies. This adds to the economic burden for the patients. Ideally, generic drugs should be prescribed to decrease the healthcare cost and to enhance the compliance. Hence, the stakeholders should aim at decreasing the cost variation among different brands while maintaining the therapeutic efficacy.
Authors and Affiliations
Ashutosh Tiwari, Pooja Reddy, Chhaya Goyal
Keywords
Related Articles
- EP ID EP240761
- DOI -
- Views 116
- Downloads 0
Extended spectrum beta-lactamase production and biofilm formation in Klebsiella pneumoniae isolates from urinary tract samples: A tertiary care hospital experiencev
Multidrug resistant Gram negative bacteria belonging to family Enterobacteriaceae are responsible for urinary tract infections UTIs that are difficult to treat Nosocomial and community acquired UTIs are known to be exist...
Ajuga bracteosa: A central Himalayan plant shows potent hypoglycemic effect in rats
Background: In the present study, a central Himalayan herb; Ajuga bracteosa Wall. ex Benth. (Neelkanthi, Ratapaati) was investigated for the probable hypoglycemic activity underlying in it. Material and Method: The hydro...
Sketchy knowledge skeptical attitude towards generic and branded drugs
Objective: The aim of the study was to evaluate the medical student’s knowledge and attitude towards generic drugs and categorize if a drug is generic or branded from the drug label. Method: A prospective cross sectional...
Evaluation of the locomotor and skeletal muscle relaxant activities of ethanolic extracts of Acacia Nilotica Linn. BARK. (Mimosaceae)
Acacia nilotica Linn. Subsp. indica (Family- Mimosaceae) bark has many activities like anti-plasmodial, molluscidal, anti-fungal, anti-microbial activity. The plant has no CNS depressant action found yet, but having such...
Development and Validation of Albendazole and Praziquental
A simple, precise and accurate RP-HPLC method has been developed for simultaneous estimation of Albendazole and Praziquental. A mixture of 20 volumes of phosphate buffer pH 4.0:70 volumes of acetonitrile: 10 volumes of m...